Dolby Laboratories, Inc. DLB
Set alert
At close · Oct 30
After hours · Oct 30, 4:01 PM ET
- YTD
- -3.47%
- 1 year
- -5.59%
- Open
- 63.07
- Prev close
- 62.91
- Mkt cap
- 5.81B
- Vol
- 688.77K
- Avg vol
- 866.01K
- EPS
- 2.35
- P/E
- 26.38
- Div yield
- 2.29%
More statistics
- Low
- 61.54
- High
- 63.41
- Forward P/E
- 13.54
- Beta
- 0.78
- Short ratio
- 7.01
- Inst. own
- 107.47%
- Dividend
- 1.44
- Ex-div date
- Aug 10, 2026
- Earnings
- Nov 17, 2026
- 50-d avg
- 60.82
- 200-d avg
- 59.28
- 1y target
- 79.00
5Y chart
Events in this range
- Nov 29, 2021Dividend: 0.25
- Feb 15, 2022Dividend: 0.25
- May 16, 2022Dividend: 0.25
- Aug 22, 2022Dividend: 0.25
- Nov 29, 2022Dividend: 0.27
- Dec 8, 2022Dividend: 0.27
- Feb 13, 2023Dividend: 0.27
- May 15, 2023Dividend: 0.27
- Aug 11, 2023Dividend: 0.27
- Nov 27, 2023Dividend: 0.3
- Feb 12, 2024Dividend: 0.3
- May 13, 2024Dividend: 0.3
- Aug 19, 2024Dividend: 0.3
- Dec 3, 2024Dividend: 0.33
- Feb 11, 2025Dividend: 0.33
- May 13, 2025Dividend: 0.33
- Jul 31, 2025Earnings: 0.78; estimate 0.72; surprise 8.33%
- Aug 12, 2025Dividend: 0.33
- Nov 18, 2025Earnings: 0.99; estimate 0.699; surprise 41.63%
- Dec 2, 2025Dividend: 0.36
- Jan 29, 2026Earnings: 1.06; estimate 0.993; surprise 6.75%
- Jan 30, 2026Rating: Barrington Research · Outperform → Outperform
- Feb 10, 2026Dividend: 0.36
- Apr 27, 2026Rating: Barrington Research · Outperform → Outperform
- Apr 30, 2026Earnings: 1.37; estimate 1.31; surprise 4.58%
- May 12, 2026Dividend: 0.36
- Jun 11, 2026Rating: Rosenblatt · Buy → Buy
- Jun 15, 2026Rating: Barrington Research · Outperform → Outperform
- Jul 30, 2026Earnings: 0.69; estimate 0.671; surprise 2.83%
- Jul 31, 2026Rating: Rosenblatt · Buy → Buy
- Aug 11, 2026Dividend: 0.36
- Aug 28, 2026Rating: Rosenblatt · Buy → Buy
Signals (102)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 19, 2026 | 1 week ago |
| SMA: Bullish | Sep 21, 2026 | 1 month ago |
| SMA: Bearish | Sep 14, 2026 | 1 month ago |
| SMA: Bearish | Sep 14, 2026 | 1 month ago |
| SMA: Bullish | Jul 27, 2026 | 3 months ago |
| SMA: Bullish | Jul 27, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 27, 2026 | 3 months ago |
| MACD: Sell Signal | May 4, 2026 | 6 months ago |
| SMA: Bearish | Apr 27, 2026 | 6 months ago |
| SMA: Bullish | Apr 13, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 13, 2026 | 6 months ago |
| MACD: Sell Signal | Mar 16, 2026 | 7 months ago |
| SMA: Bearish | Mar 9, 2026 | 7 months ago |
| SMA: Bullish | Feb 23, 2026 | 8 months ago |
| SMA: Bearish | Feb 16, 2026 | 8 months ago |
| SMA: Bullish | Feb 2, 2026 | 9 months ago |
| MACD: Buy Signal | Feb 2, 2026 | 9 months ago |
| SMA: Bearish | Dec 15, 2025 | 10 months ago |
| SMA: Bullish | Dec 8, 2025 | 10 months ago |
| SMA: Bearish | Aug 25, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 25, 2025 | 1 year ago |
| SMA: Bullish | Aug 18, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 18, 2025 | 1 year ago |
| SMA: Bearish | Jul 28, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 28, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 14, 2025 | 1 year ago |
| SMA: Bullish | Jun 30, 2025 | 1 year ago |
| SMA: Bearish | Jun 9, 2025 | 1 year ago |
| SMA: Bullish | Jun 2, 2025 | 1 year ago |
| SMA: Bearish | May 19, 2025 | 1 year ago |
| SMA: Bullish | May 12, 2025 | 1 year ago |
| SMA: Bearish | Mar 31, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 24, 2025 | 1 year ago |
| SMA: Bearish | Mar 17, 2025 | 1 year ago |
| SMA: Bullish | Jan 13, 2025 | 1 year ago |
| SMA: Bearish | Jan 6, 2025 | 1 year ago |
| SMA: Bullish | Nov 18, 2024 | 1 year ago |
| SMA: Bullish | Nov 18, 2024 | 1 year ago |
| SMA: Bearish | Nov 11, 2024 | 1 year ago |
| SMA: Bullish | Oct 28, 2024 | 2 years ago |
| SMA: Bearish | Oct 21, 2024 | 2 years ago |
| MACD: Buy Signal | Sep 30, 2024 | 2 years ago |
| SMA: Bullish | Sep 16, 2024 | 2 years ago |
| RSI: Oversold | Aug 5, 2024 | 2 years ago |
| SMA: Bearish | May 20, 2024 | 2 years ago |
| SMA: Bearish | May 20, 2024 | 2 years ago |
| MACD: Sell Signal | May 20, 2024 | 2 years ago |
| SMA: Bullish | May 13, 2024 | 2 years ago |
| MACD: Buy Signal | May 13, 2024 | 2 years ago |
| SMA: Bullish | Apr 29, 2024 | 2 years ago |
| SMA: Bearish | Apr 8, 2024 | 2 years ago |
| SMA: Bearish | Apr 1, 2024 | 2 years ago |
| MACD: Sell Signal | Apr 1, 2024 | 2 years ago |
| MACD: Buy Signal | Mar 25, 2024 | 2 years ago |
| SMA: Bullish | Mar 11, 2024 | 2 years ago |
| SMA: Bullish | Mar 4, 2024 | 2 years ago |
| SMA: Bearish | Jan 29, 2024 | 2 years ago |
| MACD: Sell Signal | Jan 15, 2024 | 2 years ago |
| SMA: Bearish | Jan 1, 2024 | 2 years ago |
| SMA: Bullish | Nov 20, 2023 | 2 years ago |
| SMA: Bearish | Nov 13, 2023 | 2 years ago |
| MACD: Buy Signal | Nov 6, 2023 | 2 years ago |
| SMA: Bullish | Oct 30, 2023 | 3 years ago |
| SMA: Bullish | Oct 30, 2023 | 3 years ago |
| SMA: Bearish | Sep 4, 2023 | 3 years ago |
| SMA: Bearish | Sep 4, 2023 | 3 years ago |
| SMA: Bullish | Aug 28, 2023 | 3 years ago |
| SMA: Bullish | Aug 28, 2023 | 3 years ago |
| SMA: Bearish | Aug 21, 2023 | 3 years ago |
| SMA: Bearish | Aug 21, 2023 | 3 years ago |
| SMA: Bullish | Aug 14, 2023 | 3 years ago |
| SMA: Bullish | Aug 14, 2023 | 3 years ago |
| SMA: Bearish | Jul 31, 2023 | 3 years ago |
| SMA: Bearish | Jul 31, 2023 | 3 years ago |
| MACD: Sell Signal | Jul 31, 2023 | 3 years ago |
| MACD: Buy Signal | Jul 10, 2023 | 3 years ago |
| SMA: Bullish | Jun 26, 2023 | 3 years ago |
| SMA: Bearish | Jun 19, 2023 | 3 years ago |
| SMA: Bullish | Jun 12, 2023 | 3 years ago |
| SMA: Bearish | May 15, 2023 | 3 years ago |
| MACD: Sell Signal | May 15, 2023 | 3 years ago |
| SMA: Bullish | Mar 20, 2023 | 3 years ago |
| SMA: Bearish | Mar 6, 2023 | 3 years ago |
| SMA: Bullish | Jan 2, 2023 | 3 years ago |
| SMA: Bullish | Dec 26, 2022 | 3 years ago |
| SMA: Bearish | Dec 19, 2022 | 3 years ago |
| SMA: Bearish | Dec 12, 2022 | 3 years ago |
| SMA: Bullish | Nov 28, 2022 | 3 years ago |
| MACD: Buy Signal | Nov 14, 2022 | 3 years ago |
| SMA: Bullish | Nov 7, 2022 | 3 years ago |
| MACD: Sell Signal | Sep 26, 2022 | 4 years ago |
| SMA: Bearish | Aug 22, 2022 | 4 years ago |
| SMA: Bearish | Aug 22, 2022 | 4 years ago |
| SMA: Bullish | Jul 25, 2022 | 4 years ago |
| SMA: Bullish | Jul 18, 2022 | 4 years ago |
| SMA: Bearish | Jun 27, 2022 | 4 years ago |
| SMA: Bullish | Jun 20, 2022 | 4 years ago |
| SMA: Bearish | Jun 6, 2022 | 4 years ago |
| SMA: Bullish | May 23, 2022 | 4 years ago |
| SMA: Bearish | May 2, 2022 | 4 years ago |
| SMA: Bullish | Mar 28, 2022 | 4 years ago |
| SMA: Bearish | Jan 17, 2022 | 4 years ago |
Key statistics
- Market cap
- 5.81B
- Enterprise value
- 5.28B
- Trailing P/E
- 26.39
- Forward P/E
- 13.54
- PEG ratio
- 1.29
- Price / sales
- 4.29
- Price / book
- 2.25
- EPS (TTM)
- 2.35
- Beta
- 0.78
- Dividend yield
- 2.29%
- Payout ratio
- 60.00%
- Profit margin
- 16.70%
- Revenue (TTM)
- 1.35B
- Revenue growth
- -3.30%
- Free cash flow
- 331.85M
- Total cash
- 670.05M
- Total debt
- 47.45M
- Return on equity
- 8.76%
- Shares outstanding
- 59.42M
- Short % of float
- 13.50%
- 50-day average
- 60.82
- 200-day average
- 59.28
Analyst view
Consensus: buy
- Target (low)
- 62.00
- Target (mean)
- 79.00
- Target (high)
- 90.00
- Strong buy1
- Buy2
- Hold1
- Sell0
- Strong sell0
Next earnings
Nov 17, 2026
Expected Nov 17, 2026. Consensus EPS estimate 1.20.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 17, 2026 | Sep 26, 2026 | 1.19 | — | — | — |
| Jul 30, 2026 | Jun 26, 2026 | 0.671 | 0.69 | +0.02 | +2.83% |
| Apr 30, 2026 | Mar 27, 2026 | 1.31 | 1.37 | +0.06 | +4.58% |
| Jan 29, 2026 | Dec 26, 2025 | 0.993 | 1.06 | +0.07 | +6.75% |
| Nov 18, 2025 | Sep 26, 2025 | 0.699 | 0.99 | +0.29 | +41.63% |
| Jul 31, 2025 | Jun 27, 2025 | 0.72 | 0.78 | +0.06 | +8.33% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 28, 2026 | Rosenblatt | main | Buy | Buy |
| Jul 31, 2026 | Rosenblatt | main | Buy | Buy |
| Jun 15, 2026 | Barrington Research | main | Outperform | Outperform |
| Jun 11, 2026 | Rosenblatt | main | Buy | Buy |
| Apr 27, 2026 | Barrington Research | main | Outperform | Outperform |
| Jan 30, 2026 | Barrington Research | main | Outperform | Outperform |
About Dolby Laboratories, Inc.
Dolby Laboratories, Inc. engages in the design and manufacture of audio, imaging, accessibility, and other hardware and software solutions for television, broadcast, and live entertainment industries in the United States and internationally. The company develops and licenses its audio technologies, such as AAC, HE-AAC, and extended HE-AAC, a digital audio codec solution; AVC, a digital video codec used in STBs, mobile devices, cameras, and broadcast television services and other products; and Dolby Atmos and Dolby Vision include encoding technologies that artists use to create more compelling and immersive audio and video experiences. It also provides DD+, an advanced surround sound audio codec technology; Dolby AC-4, an audio codec that uses cutting edge compression; and HEVC, a digital video codec that compresses video. In addition, the company offers Dolby Cinemas, a premium large format cinemas that deliver a Dolby branded premium cinema offering with Dolby Vision, Dolby Atmos, and a Dolby theater design; Dolby.io, a SaaS product of immersive, interactive, and social experiences with real-time engagement for live events, especially sports; and digital cinema servers, cinema processors, amplifiers, loudspeakers, and audio and imaging hardware and software products for the cinema, television, broadcast, communication, and entertainment industries. Further, it provides various services to support theatrical and television production for cinema exhibition, broadcast, and home entertainment. It serves film studios, content creators, post-production facilities, and broadcasters. Dolby Laboratories, Inc. was founded in 1965 and is headquartered in San Francisco, California.
- Sector
- Industrials
- Industry
- Specialty Business Services
- Country
- United States
- Website
- dolby.com
News
- CervoMed Announces Publication of Two Peer-Reviewed Research Articles Supporting Neflamapimod as a Potential Treatment for Dementia with Lewy Bodies (DLB)
- Dolby Laboratories Announces Conference Call and Webcast for Q4 Fiscal 2026 Financial Results
- Dolby Laboratories (NYSE:DLB) & Palo Alto Networks (NASDAQ:PANW) Financial Contrast
- Analyzing Dolby Laboratories (NYSE:DLB) & Aware (NASDAQ:AWRE)
- Dolby Laboratories: Weak Growth, But The Valuation Is Too Cheap
- Cognition Therapeutics Schedules a Type C Meeting with FDA to Align on Endpoints for Phase 3 Trial of Zervimesine (CT1812) in DLB
- Dolby Expands Meta Partnership With Atmos and Vision Across Devices
- Your Meta AI Glasses Are Getting a Dolby Upgrade
- Financial Analysis: Zscaler (NASDAQ:ZS) vs. Dolby Laboratories (NYSE:DLB)
- Dolby and Meta Expand Dolby Atmos and Dolby Vision Across Meta's Ecosystem
Your note
Sign in to keep a note on DLB — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| COULING JOHN D | Officer | Sale | Sep 30, 2026 | 166,803 |
| DOLBY DAVID | Director and Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) | Feb 2, 2026 | 92,718 |
| GOTCHER PETER C | Director | Stock Award(Grant) | Feb 2, 2026 | 44,641 |
| PARK ROBERT J. | Chief Financial Officer | Sale | May 11, 2026 | 81,490 |
| REVANKAR SHRIRAM | Officer | Sale | Aug 13, 2026 | 73,274 |
| SEGARS SIMON | Director | Stock Award(Grant) | Feb 2, 2026 | 47,150 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 11.24% | 6,676,885 | 414.13M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 8.33% | 4,950,702 | 307.07M | Jun 29, 2026 |
| Bank Of New York Mellon Corporation | 8.11% | 4,817,216 | 298.79M | Jun 29, 2026 |
| Morgan Stanley | 7.74% | 4,601,750 | 285.42M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 4.58% | 2,721,876 | 168.82M | Jun 29, 2026 |
| First Trust Advisors LP | 4.55% | 2,705,504 | 167.81M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Eaton Vance Growth Trust-Eaton Vance Atlanta Capital SMID-Cap Fund | 3.73% | 2,217,691 | 137.55M | Jun 29, 2026 |
| iShares Trust-iShares Core S&P Mid-Cap ETF | 3.56% | 2,114,326 | 131.14M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.23% | 1,921,198 | 119.16M | Jun 29, 2026 |
| VANGUARD WORLD FUND-Vanguard Information Technology Index Fund | 2.60% | 1,546,086 | 95.90M | Aug 30, 2026 |
| First TRT Exch-Trd Fd. VI-First TRT SMID Cap Rising Dividend Achievers | 2.59% | 1,538,407 | 95.42M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.33% | 1,384,564 | 85.88M | Jun 29, 2026 |